Non-Current Assets
Indefinite-Lived Intangible Assets
Boston Scientific Indefinite-Lived Intangible Assets decreased by 5.3% to $770M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 719.1%, from $94M to $770M. Over 5 years (FY 2020 to FY 2025), Indefinite-Lived Intangible Assets shows an upward trend with a 16.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2019
Last reportedQ1 2026May 1, 2026
Metric ID:
indefinite_lived_intangible_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $330M | $374M | $246M | $246M | $232M | $232M | $232M | $232M | $174M | $174M | $174M | $174M | $214M | $94M | $94M | $94M | $813M | $813M | $813M | $770M |
| QoQ Change | — | +13.3% | -34.2% | +0.0% | -5.7% | +0.0% | +0.0% | +0.0% | -25.0% | +0.0% | +0.0% | +0.0% | +23.0% | -56.1% | +0.0% | +0.0% | +764.9% | +0.0% | +0.0% | -5.3% |
| YoY Change | — | — | — | — | -29.7% | -38.0% | -5.7% | -5.7% | -25.0% | -25.0% | -25.0% | -25.0% | +23.0% | -46.0% | -46.0% | -46.0% | +279.9% | +764.9% | +764.9% | +719.1% |
Range$94M – $813M
CAGR+19.5%
Avg YoY Growth+139.7%
Median YoY Growth-25.0%
Indefinite-Lived Intangible Assets at Other Companies
Frequently Asked Questions
- What is Boston Scientific's indefinite-lived intangible assets?
- Boston Scientific (BSX) reported indefinite-lived intangible assets of $770M in Q1 2026.
- How has Boston Scientific's indefinite-lived intangible assets changed year-over-year?
- Boston Scientific's indefinite-lived intangible assets increased by 719.1% year-over-year, from $94M to $770M.
- What is the long-term trend for Boston Scientific's indefinite-lived intangible assets?
- Over 5 years (2020 to 2025), Boston Scientific's indefinite-lived intangible assets has grown at a 16.6% compound annual growth rate (CAGR), from $377M to $813M.